| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 890 | $100 | $85.9K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,810 | $30 | $73.1K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 2,080 | $30 | $70.5K |
| 77085 | The provider measures the mineral density of the bones of the axial skeleton and assesses a vertebral fracture. He performs the procedure to assess the patient for the presence of osteoporosis or… | 990 | $50 | $52.4K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 270 | $160 | $43.8K |
| 77089 | The provider uses imaging data and software to calculate a patient’s trabecular bone score. The service includes an interpretation and report on the patient’s fracture risk. | 1,030 | $30 | $31K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 180 | $110 | $18.8K |
| J0897 | Injection, denosumab, 1 mg | 960 | $20 | $16.3K |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 30 | $550 | $14.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 200 | $70 | $13.3K |